文献速递结核与非结核分枝杆菌新发突发、热带与寄生虫病

社区结核筛查:单独计算机辅助检测与联用C反应蛋白即时检测的配对筛查阳性试验

Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial.
PubMed 文献 · Lancet Infect Dis · 2026-07-01

BACKGROUND: Active tuberculosis case-finding in communities is crucial for early disease detection and disruption of transmission; however, it is complex and costly.…

要点

  • 单独CAD筛查结核的病例检出率高于CAD后加做CRP的联合策略。
  • 联合策略未达到预设的非劣效界值(-10%),且每检出1例成本更高。
  • 在结核高负担社区,单独CAD可能是有成本效益的主动筛查策略。

核心结论

  • 在社区主动结核病例发现中,CAD后加做CRP检测相比单独CAD无优势,因检出病例更少且成本更高。
  • 单独CAD在高疾病负担地区可能是一种有效且经济可行的结核筛查策略。

研究设计与样本

  • 实用社区试验,采用配对筛查阳性设计(个体内比较),在莱索托Butha-Buthe区和南非uMgungundlovu区开展。
  • 纳入所有家庭中年龄≥18岁成员,排除病情严重、无法安全完整参与、正在接受结核治疗者,莱索托还排除孕妇。
  • 主要结局为CAD4TBv7-CRP相比CAD4TBv7的非劣效性(界值-10%)及成本比较。

主要发现

  • 主要分析集包含73例经任一策略识别且两策略数据完整的结核病例。
  • CAD4TBv7策略每检出1例结核成本为5454美元(95%不确定性区间4294-6777)。

关键数值与推荐

  • CAD4TBv7-CRP策略每检出1例成本7486美元(95%不确定性区间5948-9246),CAD4TBv7策略为5454美元(4294-6777)。

临床怎么用

  • 在资源有限的结核高负担社区,可优先考虑单独使用CAD软件判读数字胸片进行主动筛查。
  • 不推荐在CAD判读后常规加做CRP即时检测用于社区结核筛查,因其降低病例检出且增加成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Active tuberculosis case-finding in communities is crucial for early disease detection and disruption of transmission; however, it is complex and costly. A thorough analysis of tuberculosis screening strategies is essential, particularly because the health systems affected often have limited resources. We aimed to compare two community screening approaches in terms of tuberculosis case yield and cost. METHODS: This pragmatic community trial, with a paired screen-positive design (ie, within-person comparison), was conducted in the Butha-Buthe District in Lesotho and the uMgungundlovu District in South Africa. All household members aged at least 18 years were eligible to participate, except those who were seriously ill, had a condition that prevented their safe and full participation, were receiving tuberculosis treatment, or were pregnant (Lesotho only). We compared two screening approaches: the use of computer-aided detection (CAD) software on digital chest x-rays alone (the CAD4TBv7 approach) and the use of CAD followed by a C-reactive protein (CRP) test if the CAD score was in a particular range (the CAD4TBv7-CRP approach). A confirmatory Xpert MTB/RIF Ultra test was conducted when required by the algorithm of one or both approaches. Coprimary outcomes were to establish whether the CAD4TBv7-CRP approach was non-inferior to the CAD4TBv7 approach (non-inferiority margin -10%) and to conduct a comparative cost analysis between the two approaches. FINDINGS: Among 20 023 enrolled participants, the median age was 42 years (IQR 29-60); 12 387 (61·9%) participants were female, 7625 (38·1%) were male, and 11 (0·1%) were intersex. 4534 (22·6%) of 20 023 participants were living with HIV, 1547 (7·7%) had a history of tuberculosis, and 1545 (7·7%) reported at least one of the four main symptoms of tuberculosis. The primary outcome set, defined as participants who were identified as having tuberculosis according to at least one of the two approaches and had complete data for both approaches, comprised 73 participants: the CAD4TBv7 approach identified 69 (94·5%) of these cases of tuberculosis and the CAD4TBv7-CRP approach identified 60 (82·2%) cases. The difference of -12·3% (95% CI -23·0 to -1·6) indicates that the non-inferiority criterion was not met. The cost per detected case of tuberculosis was US$5454 (95% uncertainty interval 4294-6777) for the CAD4TBv7 approach and $7486 (5948-9246) for the CAD4TBv7-CRP approach, making the CAD4TBv7-CRP approach 37·3% more expensive. INTERPRETATION: In active tuberculosis case-finding in our community setting, the combination of CAD followed by CRP testing offered no advantage over CAD alone owing to its inferior case yield and higher cost. CAD alone, however, has the potential to be an effective and economically viable tuberculosis screening strategy in areas with high disease burden. FUNDING: The European and Developing Countries Clinical Trials Partnership.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Reither K, Vanobberghen F, Verjans A, et al. Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial. Lancet Infect Dis. 2026. PMID: 42385764. doi:10.1016/S1473-3099(26)00222-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。